Reaching multidisciplinary consensus on the management of non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer-Reference-Cited by-同舟云学术

Reaching multidisciplinary consensus on the management of non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer

Published:2023-03 Issue: Volume:177 Page:21-28
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Scherpereel Arnaud,Martin Etienne,Brouchet Laurent,Corre Romain,Duruisseaux Michaël,Falcoz Pierre-Emmanuel,Giraud Philippe,Le Péchoux Cécile,Wislez Marie,Alifano Marco

Funder

AstraZeneca France

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA(N2) and selected IIIB non-small-cell lung cancer after induction chemotherapy and concurrent chemoradiotherapy (ESPATUE);Eberhardt;J Clin Oncol.,2015

2. The reality of lung cancer paradox: The impact of body mass index on long-term survival of resected lung cancer. A French nationwide analysis from the Epithor database;Alifano;Cancers (Basel),2021

3. Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial;Senan;ESMO Open.,2022

4. What is the role of surgery in potentially resectable N2 non-small cell lung cancer?;Evison;Thorax.,2018

5. The role of surgery in management of locally advanced non-small cell lung cancer;Bryan;Curr Treat Options Oncol.,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA–B GFPC 04-2020Study);Lung Cancer;2024-08

2. Contemporary Strategies: Incorporating Immunotherapy into Stage 3 Non-small Cell Lung Cancer Treatment;Tuberculosis and Respiratory Diseases;2024-07-01

3. The analysis of current international recommendations for the treatment of patients with stage III non-small cell lung cancer;Grekov's Bulletin of Surgery;2024-05-19

4. Multidisziplinäres Management des N2-metastasierten Nichtkleinzellers;TumorDiagnostik & Therapie;2024-02

5. Étude GFPC OBSERVE IIIA-B : analyse prospective des pratiques thérapeutiques françaises dans les cancers bronchiques non à petites cellules de stade III N2;Revue des Maladies Respiratoires Actualités;2024-01